Benign Prostatic Hyperplasia: Diagnosis and Treatment: Clinical Practice GuidelineDIANE Publishing, 1995 - 225 pages Developed to apply to the typical man over age 50 with symptoms of prostatism, but with no significant medical morbidities such as diabetes. Contains recommendations for patient evaluation, symptom assessment, and diagnostic tests. Intended for clinicians and other health care providers who examine and treat men with BPH or who are otherwise involved in the care of patients with BPH. 42 tables and figures. |
From inside the book
Results 1-5 of 36
Page 3
... normal and abnormal test values are uncertain . Test results thus do not accurately define the severity of BPH . Use of the tests is not mandatory prior to a decision to treat typical patients with a high probability of BPH based on the ...
... normal and abnormal test values are uncertain . Test results thus do not accurately define the severity of BPH . Use of the tests is not mandatory prior to a decision to treat typical patients with a high probability of BPH based on the ...
Page 9
... normal daytime activities or sleep , create anxiety , or reduce perception of general health , the quality of life can decline significantly . Yet , the degree of " bothersomeness " may be dramatically different for different patients ...
... normal daytime activities or sleep , create anxiety , or reduce perception of general health , the quality of life can decline significantly . Yet , the degree of " bothersomeness " may be dramatically different for different patients ...
Page 13
... normal and abnormal test values may be uncertain . The evidence is thus insufficient to mandate use of the test prior to a decision to treat . If a test was not recommended , the panel believed there is sufficient evidence to indicate ...
... normal and abnormal test values may be uncertain . The evidence is thus insufficient to mandate use of the test prior to a decision to treat . If a test was not recommended , the panel believed there is sufficient evidence to indicate ...
Page 22
... ( normal , benign hyperplastic , and malignant ) , it could not be found in any other human tissue . Thus , it became known as prostate- specific antigen . PSA is a glycoprotein with kallikrein - like serine protease activity produced by ...
... ( normal , benign hyperplastic , and malignant ) , it could not be found in any other human tissue . Thus , it became known as prostate- specific antigen . PSA is a glycoprotein with kallikrein - like serine protease activity produced by ...
Page 24
... normal of 5 ng / mL , found that 21 of 45 patients ( 47 percent ) with histologically proven BPH had an elevated serum PSA level . Filella , Molina , Jo , et al . ( 1990 ) , also utilizing the Tandem - R PSA assay , found that 87 ...
... normal of 5 ng / mL , found that 21 of 45 patients ( 47 percent ) with histologically proven BPH had an elevated serum PSA level . Filella , Molina , Jo , et al . ( 1990 ) , also utilizing the Tandem - R PSA assay , found that 87 ...
Other editions - View all
Common terms and phrases
adverse effects alpha blocker antigen assessment balloon dilation benign prostatic hyperplasia benign prostatic hypertrophy bladder neck contracture BPH patients BPH treatment Bruskewitz complications correlation detrusor diagnostic disease Dorflinger double-blind drug efficacy estimated evaluation failure rate finasteride following TURP followup Health Holtgrewe hospital stay impotence incidence long-term measurement Mebust Medical Meyhoff mL/sec ng/mL number of patients open prostatectomy open surgery panel patient preference patients with BPH percent 90-percent percent of patients placebo postvoid residual urine prazosin pressure-flow studies probability procedure prostate cancer prostate-specific antigen Qmax recommended reported Retropubic prostatectomy risk Scand J Urol sexual Suprapubic prostatectomy symptom improvement symptom score symptomatic symptoms of prostatism terazosin therapy transurethral incision transurethral prostatectomy transurethral resection treatment for BPH treatment modalities treatment of benign treatment option Treatment Outcomes TUIP ultrasonography urethral stricture Urethrocystoscopy urinary incontinence urinary retention urinary tract infection urodynamic uroflowmetry Urol Nephrol Urology voiding watchful waiting
Popular passages
Page 151 - Abrams PH, Griffiths DJ. The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol 1979;51:129-34. Adar R, Critchfield GC, Eddy DM. A confidence profile analysis of the results of
Page 167 - TN, Bashore TM. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographie contrast agent, N Engl J Med 1989;320:149-53. Scott FB, Cardus D, Quesada EM, Riles T. Uroflowmetry before and after prostatectomy.
Page 168 - Retropubic and suprapubic prostatectomy: comparative clinical study. J Urol 1955;74:129-37. Taylor Z, Krakauer H. Mortality and reoperation following prostatectomy: outcomes in a medicare population. Urology (Suppl 1) 1991;38:27-31. Thompson IM, Ernst JJ, Gangai MP, Spence CR. Adenocarcinoma of the prostate: results of routine urological screening. J Urol 1984; 132:690-2.
Page 167 - M011er-Madsen B, Dorflinger T, N0rgaard JP, J0rgensen HS, Lundhus E: The significance of age on symptoms and urodynamic and cystoscopic findings in benign prostatic hypertrophy. Urol Res 1987; 15:355-8. Singh M, Tresidder GC, Blandy JP. The evaluation of transurethral resection for benign enlargement of the prostate. Br J Urol 1973;45:93-102. Siroky MB,
Page 32 - month, how many times did you most typically get up to urinate from the time you went to bed at night
Page 166 - Rollema HJ, van Mastrigt R. Objective analysis of prostatism: a clinical application of the computer program CLIM. Neurourol Urodyn 1991;10:71-6. Rollema HJ, van Mastrigt R, Janknegt RA. Urodynamic assessment and quantification of prostatic obstruction before and after transurethral resection of the prostate: standardization with the aid of the computer program
Page 159 - Holtgrewe HL, Valk WL. Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2,015 cases. J Urol 1962;87:450-9. Holtgrewe HL, Valk WL. Late results of transurethral prostatectomy. J Urol 1964;92:51-5.
Page 178 - of medical students, residents, and urologists, He is a Fellow of the American College of Surgeons and a
Page 168 - DB. Retropubic prostatectomy, 1947-1960: A critical evaluation. J Urol 1961;85:322-8. Stephenson WP, Chute CG, Guess HA, Schwartz S, Lieber M. Incidence and outcome of surgery for benign prostatic hyperplasia among residents of Rochester,
Page 207 - J. Transurethral resection of the prostate and bladder neck incision: a review of 700 cases. Br J Urol 1985;57:168-71. Hellström P, Lukkarinen O,